Selection of tissue factor-deficient bone marrow stromal cell
transplants as a novel strategy to improve therapeutic
applicability
Oeller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk, D
Human Gene Therapy. 2017; 28: A97-A98.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)